Nephrocalcinosis in animal models with and without stones

Urological Research

Volumn 38, Issue 6, 2010, Pages 429-438

  Khan, Saeed R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Calcium oxalate; Calcium phosphate; Napt2a null mice; Nephrocalcinosis; Nephrolithiasis

Indexed keywords

CALCIUM OXALATE; CALCIUM PHOSPHATE; CALCIUM SALT; OSTEOPONTIN; SODIUM PHOSPHATE COTRANSPORTER; SODIUM PROTON EXCHANGE PROTEIN; TAMM HORSFALL GLYCOPROTEIN;

CONFERENCE PAPER; CRYSTALLIZATION; DISEASE MODEL; HYPEROXALURIA; KIDNEY CALCIFICATION; KIDNEY COLLECTING TUBULE; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; KIDNEY TUBULE; MOUSE; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; STONE FORMATION; SWINE;

ANIMALS; CALCIUM OXALATE; CALCIUM PHOSPHATES; DISEASE MODELS, ANIMAL; KIDNEY; MICE; NEPHROCALCINOSIS; OSTEOPONTIN; RATS; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIA; SWINE; UROMODULIN;

EID: 78651280397     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-010-0303-4     Document Type: Conference Paper

References (69)

1. Evan AP (2010) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 25(5):831-841.
2. Randall A (1937) The origin and growth of renal calculi. Ann Surg 105:1009.
3. Low RK, Stoller ML (1997) Endoscopic mapping of renal papillae for Randall's plaques in patients with urinary stone disease. J Urol 158:2062.
4. Low RK, Stoller ML, Schreiber CK (2000) Metabolic and urinary risk factors associated with Randall's papillary plaques. J Endourol 14:507.
5. Stoller ML, Low RK, Shami GS et al (1996) High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall's plaque formation. J Urol 156:1263.
6. Evan AP, Coe FL, Lingeman JE et al (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69:2227.
7. Evan AP, Lingeman J, Coe F et al (2007) Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 71:795.
8. Evan AP, Lingeman JE, Coe FL et al (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576.
9. Evan AP, Lingeman JE, Coe FL et al (2008) Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 28:111.
10. Evan AP, Lingeman JE, Coe FL et al (2003) Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607.
11. Evan AP, Coe FL, Gillen D et al (2008) Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken) 291:325
12. Khan SR, Finlayson B, Hackett R (1984) Renal papillary changes in patient with calcium oxalate lithiasis. Urology 23:194.
13. Asplin JR, Mandel NS, Coe FL (1996) Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604.
14. Conyers RA, Bais R, Rofe AM (1986) Oxalosis and the E-Ferol toxicity syndrome. JAMA 256:2677.
15. Khan SR (1997) Animal models of kidney stone formation: an analysis. World J Urol 15:236.
16. McMartin K (2009) Are calcium oxalate crystals involved in the mechanism of acute renal failure in ethylene glycol poisoning? Clin Toxicol (Phila) 47:859.
17. Khan SR, Finlayson B, Hackett RL (1979) Histologic study of the early events in oxalate induced intranephronic calculosis. Invest Urol 17:199.
18. Khan SR, Finlayson B, Hackett RL (1982) Experimental calcium oxalate nephrolithiasis in the rat. Role of the renal papilla. Am J Pathol 107:59.
19. Khan SR, Hackett RL (1991) Retention of calcium oxalate crystals in renal tubules. Scanning Microsc 5:707.
20. Khan SR, Finlayson B, Hackett RL (1983) Experimental induction of crystalluria in rats using mini-osmotic pumps. Urol Res 11:199.
21. Marengo SR, Chen DH, Evan AP et al (2006) Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis. Urol Res 34:200.
22. Marengo SR, Zhang A, Traverso EJ (2008) Partitioning of 14C- oxalate excretion in rats during a persistent oxalate challenge. Urol Res 36:319.
23. Khan SR, Glenton PA, Byer KJ (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline. Kidney Int 70:914.
24. de Bruijn WC, Boeve ER, van Run PR et al (1995) Etiology of calcium oxalate nephrolithiasis in rats I. Can this be a model for human stone formation? Scanning Microsc 9:103.
25. de Water R, Noordermeer C, van der Kwast TH et al (1999) Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 33:761.
26. Khan SR, Shevock PN, Hackett RL (1992) Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 147:226.
27. Khan SR, Thamilselvan S (2000) Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals. Mol Urol 4:305.
28. Khan SR, Shevock PN, Hackett RL (1989) Urinary enzymes and calcium oxalate urolithiasis. J Urol 142:846.
29. Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059.
30. Thamilselvan S, Menon M (2005) Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 96:117.
31. Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75.
32. Toblli JE, Ferder L, Stella I et al (2002) Enalapril prevents fatty liver in nephrotic rats. J Nephrol 15:358.
33. Toblli JE, Ferder L, Stella I et al (2002) Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 168:1550.
34. Umekawa T, Hatanaka Y, Kurita T et al (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:635.
35. Khan SR, Kok DJ (2004) Modulators of urinary stone formation. Front Biosci 9:1450.
36. Gokhale JA, Glenton PA, Khan SR (1996) Localization of Tamm-Horsfall protein and osteopontin in a rat nephrolithiasis model. Nephron 73:456.
37. Gokhale JA, Glenton PA, Khan SR (1997) Biochemical and quantitative analysis of Tamm-Horsfall protein in rats. Urol Res 25:347.
38. Marengo SR, Chen DH, Kaung HL et al (2002) Decreased renal expression of the putative calcium oxalate inhibitor Tamm- Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis. J Urol 167:2192.
39. Katsuma S, Shiojima S, Hirasawa A et al (2002) Global analysis of differentially expressed genes during progression of calcium oxalate nephrolithiasis. Biochem Biophys Res Commun 296:544.
40. Khan SR, Johnson JM, Peck AB et al (2002) Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 168:1173.
41. Suzuki K, Tanaka T, Miyazawa K et al (1999) Gene expression of prothrombin in human and rat kidneys: basic and clinical approach. J Am Soc Nephrol 10(Suppl 14):S408.
42. Iida S, Inoue M, Yoshii S et al (1999) Molecular detection of heparan sulfate proteoglycan mRNA in rat kidney during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10(Suppl 14):S412.
43. MoriyamaMT, Glenton PA, Khan SR (2001) Expression of inter alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 165:1687.
44. Mandel NS, Henderson JD Jr, Hung LY et al (2004) A porcine model of calcium oxalate kidney stone disease. J Urol 171:1301.
45. Kaplon DM, Penniston KL, Darriet C et al (2010) Hydroxyproline-induced hyperoxaluria using acidified and traditional diets in the porcine model. J Endourol 24(3):355-359.
46. Mo L, Liaw L, Evan AP et al (2007) Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both. Am J Physiol Renal Physiol 293:F1935.
47. Wesson JA, Johnson RJ, Mazzali M et al (2003) Osteopontin is a critical inhibitor of calcium oxalate crystal formation and reten tion in renal tubules. J Am Soc Nephrol 14:139.
48. Okada A, Nomura S, Higashibata Y et al (2007) Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol Res 35:89.
49. Okada A, Yasui T, Hamamoto S et al (2009) Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of mac rophage activity. J Bone Miner Res 24:908.
50. Khan SR, Glenton PA (2008) Calcium oxalate crystal deposition in kidneys of hypercalciuric mice with disrupted type IIa sodiumphosphate cotransporter. Am J Physiol Renal Physiol 294:F1109.
51. Bushinsky DA, Frick KK, Nehrke K (2006) Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens 15:403.
52. Bushinsky DA, Parker WR, Asplin JR (2000) Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57:550.
53. Bushinsky DA, Grynpas MD, Asplin JR (2001) Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 59:1415.
54. Bushinsky DA, Asplin JR, Grynpas MD et al (2002) Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61:975.
55. Okamoto N, Aruga S, Tomita K et al (2007) Chronic acid ingestion promotes renal stone formation in rats treated with vitamin D3. Int J Urol 14:60.
56. Khan SR, Glenton PA (1995) Deposition of calcium phosphate and calcium oxalate crystals in the kidneys. J Urol 153:811.
57. Hennequin C, Tardivel S, Medetognon J et al (1998) A stable animal model of diet-induced calcium oxalate crystalluria. Urol Res 26:57.
58. Serafini-Cessi F, Malagolini N, Cavallone D (2003) Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 42:658.
59. Atmani F, Glenton PA, Khan SR (1998) Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26:201.
60. Hess B, Nakagawa Y, Coe FL (1989) Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257:F99.
61. Glauser A, Hochreiter W, Jaeger P et al (2000) Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects. Nephrol Dial Trans plant 15:1580.
62. Jaggi M, Nakagawa Y, Zipperle L et al (2007) Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol Res 35:55.
63. Hess B, Nakagawa Y, Parks JH et al (1991) Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol 260:F569.
64. Mo L, Huang HY, Zhu XH et al (2004) Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 66:1159.
65. Bates JM, Raffi HM, Prasadan K et al (2004) Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 65:791.
66. Anderson JC, Williams JC Jr, Evan AP et al (2007) Analysis of urinary calculi using an infrared microspectroscopic surface reflectance imaging technique. Urol Res 35:41.
67. Beck L, Karaplis AC, Amizuka N et al (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA 95:5372.
68. Tenenhouse HS, Gauthier C, Martel J et al (2002) Na/P(i) cotransporter (Npt2) gene disruption increases duodenal calcium absorption and expression of epithelial calcium channels 1 and 2. Pflugers Arch 444:670.
69. Chau H, El-Maadawy S, McKee MD et al (2003) Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2. J Bone Miner Res 18:644